Summary
athenahealth's More Disruption Please (MDP) will feature a select group of 75 CEOs from innovative, high potential Health IT companies to explore how ways to collaborate push the boundaries of healthcare and make it work as it should. Goodwin is a sponsor of this annual event.
Related Content
- AlertJune 6, 2025
New Dental Industry Compliance Standards Take Shape: Dental Trade Alliance (DTA) Releases Revised Code of Ethics
- Big Molecule WatchJune 4, 2025
Sandoz Launches PYZCHIVA® (Ustekinumab) Autoinjector in Europe
- Big Molecule WatchJune 3, 2025
Samsung Bioepis Secures Marketing Approval in Korea for its Biosimilar to Amgen’s Bone Cancer Drug Xgeva
- Big Molecule WatchJune 2, 2025
EMA Issues Positive CHMP Opinions for Fresenius Denosumab Biosimilars
- Big Molecule WatchJune 2, 2025
Celltrion, Samsung Bioepis, and Organon Receive Interchangeability Designations for Adalimumab Biosimilars
- AlertJune 2, 2025
State Drug Transparency Laws — 2025 Update
- AlertJune 2, 2025
Prescription Drug Affordability Review Boards — 2025 Update
- Life Sciences PerspectivesMay 30, 2025
Biotech M&A and Partnerships: Innovation and Deal-Making in Challenging Markets
- Events25 June 2025 | 8:30 AM - 10:30 AM BST
Women in the Life Sciences & Healthcare Sector – Breakfast Networking Event
- Awards and RankingsJune 11, 2025
The Legal 500 US 2025 Recognizes 44 Goodwin Practices and 172 Lawyers
- In the PressJune 11, 2025
Goodwin Advises GRIN Therapeutics in $50 Million Exclusive Collaboration with Angelini Pharma to Develop and Commercialize Radiprodil Outside North America
- Press ReleaseJune 6, 2025
Goodwin Guides Septerna in Collaboration with Novo Nordisk on Oral Small Molecule Medicines for Obesity and Other Cardiometabolic Diseases for up to $2.2 Billion
- Speaking EngagementsJune 4, 2025
American Conference Institute Inaugural Summit on Life Sciences Cyber, Biosecurity and Data Privacy
- Press ReleaseJune 2, 2025
Blueprint Medicines To Be Acquired By Sanofi For $9.5 Billion Including Contingent Value Rights
- In the PressMay 27, 2025
Trump’s Drug Price Plan Seeks Leverage with FDA Withdrawal Power (Bloomberg Law)
- Press ReleaseMay 23, 2025
Goodwin Guides Orionis Biosciences in Strategic Partnership with Genentech That Could Exceed $2 Billion to Discover and Develop Molecular Glue Class Medicines for Cancer